ID
12953
Description
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01467323
Link
https://clinicaltrials.gov/show/NCT01467323
Keywords
Versions (1)
- 1/7/16 1/7/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 7, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT01467323
Eligibility Diabetes NCT01467323
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
total daily insulin dose at least 1.4 iu/kg
Data type
boolean
Alias
- UMLS CUI [1]
- C0021641
Description
oral hypoglycaemic agents
Data type
boolean
Alias
- UMLS CUI [1]
- C0359086
Description
hypoglycemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0020615
Description
proliferative retinopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0339467
Description
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
Data type
boolean
Alias
- UMLS CUI [1]
- C0201976
Description
pancreatitis
Data type
boolean
Alias
- UMLS CUI [1]
- C0030305
Similar models
Eligibility Diabetes NCT01467323
- StudyEvent: Eligibility